BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $114 | $101 | $120 | $116 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $57 | $58 | $53 | $48 |
| Inventory | $24 | $23 | $19 | $17 |
| Other Curr. Assets | $7 | $7 | $5 | $4 |
| Total Curr. Assets | $202 | $188 | $196 | $186 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $62 | $64 | $50 | $52 |
| Long-Term Investments | -$118 | $0 | $0 | $0 |
| Tax Assets | $57 | $0 | $0 | $0 |
| Other NC Assets | $118 | $0 | $0 | $0 |
| Total NC Assets | $123 | $68 | $54 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $325 | $256 | $250 | $242 |
| Liabilities | – | – | – | – |
| Payables | $8 | $7 | $4 | $5 |
| Short-Term Debt | $5 | $3 | $6 | $0 |
| Tax Payable | $1 | $1 | -$0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $69 | $67 | $54 | $48 |
| Total Curr. Liab. | $82 | $78 | $64 | $55 |
| LT Debt | $54 | $56 | $72 | $79 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $54 | $56 | $73 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $137 | $133 | $136 | $133 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$256 | -$320 | -$327 | -$336 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $444 | $443 | $440 | $444 |
| Total Equity | $188 | $123 | $114 | $109 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $325 | $256 | $250 | $242 |
| Net Debt | -$56 | -$42 | -$41 | -$38 |